Insurers and health systems usually look for labeled indications and documented criteria, not only skin symptoms
There are no such thing as a sticker containing a GLP-1 peptide
Licensed medical providers evaluate each patient and develop personalized care plans based on medical history, goals, and clinical judgment
When you see a qualified provider, theyll take your history, talk with you about your needs, concerns, and goals, and may also conduct an exam so that they can determine whether youre eligible for a prescription and what the best next steps are
External resources Phase 2 Retatrutide Trial - New England Journal of Medicine , the primary clinical source for retatrutide efficacy and safety data including sex-stratified outcomes
A CMS rule took effect in 2024 requiring those fees to be reflected at point of sale